Purchases and Sales Made in Q4 2023 in Cytokinetics Inc (CYTK)
This table provides information about the institutional ownership of Cytokinetics Inc (CYTK) during Q4 2023. The information is specifically focused on institutions that hold shares of CYTOKINETICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 09, 2024
Q4 2023
|
Artal Group S.A.
Luxembourg, N4 |
SELL
|
- |
-305K- 20.05% |
$8.19M - $25.4M
|
1.21M
$56.1M
|
|
|
Feb 12, 2024
Q4 2023
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-429K- 50.88% |
$11.5M - $35.8M
|
414K
$19.1M
|
|
|
Feb 09, 2024
Q4 2023
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-470K- 41.59% |
$12.6M - $39.3M
|
661K
$30.5M
|
|
|
Feb 14, 2024
Q4 2023
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-600K- 75.0% |
$16.1M - $50.1M
|
200K
$9.23M
|
|
|
Feb 14, 2024
Q4 2023
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-642K- 26.77% |
$17.3M - $53.6M
|
1.76M
$81.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-766K- 64.96% |
$20.6M - $63.9M
|
413K
$19.1M
|
|
|
Feb 07, 2024
Q4 2023
|
Nicholas Investment Partners, LP
Rancho Santa Fe, CA |
SELL
|
- |
-840K- 89.11% |
$22.6M - $70.1M
|
103K
$4.73M
|
|
|
Feb 13, 2024
Q4 2023
|
Pictet Asset Management Holding Sa
Carouge, V8 |
SELL
|
- |
-875K- 38.94% |
$23.5M - $73.1M
|
1.37M
$63.3M
|
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-908K- 59.19% |
$24.4M - $75.8M
|
626K
$28.9M
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-951K- 76.97% |
$25.5M - $79.4M
|
284K
$13.1M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-959K- 77.87% |
$25.8M - $80.1M
|
273K
$12.6M
|
|
|
Feb 14, 2024
Q4 2023
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-1.24M- 46.62% |
$33.3M - $103M
|
1.42M
$65.4M
|